Government slashes prices of about 39 commonly-used drugsThe drugs brought under price control include teneligliptin-an anti diabetes drug, popular anti TB drugs like Bedaquiline and Delamanid, Iv...
04 Sep, 2021, 06.55 AM IST
Mylan, TB Alliance seeks clinical trial waiver for Pretomanid drugPretomanid, a new oral treatment is a shorter more convenient option for people with extensively drug resistant (XDR) TB. The dossier for g...
01 Nov, 2019, 10.27 PM IST
USFDA okays new antibiotic for highly drug-resistant tuberculosisPretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.
16 Aug, 2019, 11.14 AM IST
Johnson and Johnson asked to cut down price of new TB drugTo ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price...
23 Oct, 2018, 06.53 PM IST
WHO announces important changes to multi drug resistant TB treatmentIn its last-issued guidance in October 2016, the WHO had restricted usage to the breakthrough drug owing to concerns around its effect on t...
17 Aug, 2018, 10.30 PM IST
Johnson & Johnson , Mylan propose ways to cut TB drugs prices in IndiaJ&J has offered to provide one course of the drug bedaquiline for free if the government buys four courses at $900 (₹58,400) each.
15 Mar, 2018, 08.56 AM IST
J&J, Macleods in talks for licence deal of tuberculosis drugThe talks, which are in early stage, will allow Macleods to manufacture generic version of the drug, a move if goes through will improve ac...
13 Mar, 2018, 08.26 AM IST
WHO invites applications from drug companies for pre-qualification of MDR TB drugsWHO said the expression of interest will be evaluated on the basis of product dossiers, which must include product data and information as ...
07 Mar, 2018, 10.00 PM IST
India's dependency on charitable program for MDR TB drugs not helping, doctors sayIndia's dependency on charity from global drug makers is making it hard for patients to access new antibiotic drugs such as bedaquiline and...
17 Nov, 2017, 02.25 PM IST
Otsuka licenses Mylan subsidiary to bring MDR TB drug delamanid to IndiaMDR TB is on the rise in India which, together with China and Russia, accounts for over half of these cases worldwide, according to a recen...
25 Aug, 2017, 11.29 PM IST
Otsuka enters deal with Mylan to bring MDR TB drug to IndiaThe Drug Controller General of India has granted Mylan’s subsidiary approval for the drug, according to a release by the company. The drug,...
24 Aug, 2017, 09.10 PM IST
Drug to treat MDRTB to be made available across the country: GovernmentUnion Health Minister J P Nadda, in a written reply, said that the states are being prepared to monitor the treatment of patients with Beda...
11 Apr, 2017, 09.30 PM IST
Govt agrees to provide new TB drug to a Bihar girlBedaquiline and Delamanid are considered the drug for patients like the Bihar girl. Both drugs can’t be bought in pharmacies and are availa...
19 Jan, 2017, 12.56 AM IST
Health Ministry dragged to court over curbs on TB drugsThe drugs –– Bedaquiline by US drugmaker J&J and Delamanid by Japanese drugmaker Otsuka Pharma –– are the only treatment option for patient...
02 Jan, 2017, 01.24 AM IST
‘Miracle drug’ for resistant Tuberculosis to be rolled out for trial todayA ‘miracle drug’ to battle multi-drug resistant tuberculosis MDR-TB, and extensively-drug resistant TB (XDR-TB), will be rolled out on Mond...
21 Mar, 2016, 11.35 AM IST
WHO adds 36 new drugs to list of essential medicinesThe move opens the way to improve access to innovative medicines that show clear clinical benefits and could have enormous public health im...
08 May, 2015, 08.40 PM IST
Europe backs new dual-action Novartis lung drugNovartis won an important endorsement of its new medicine for chronic lung disease when European regulators recommended approval of Ultibro...
26 Jul, 2013, 06.14 PM IST